What does this research mean for the field?

A newly developed 4T1-based murine model system with genetically edited CAIX expression provides a robust and validated preclinical platform for evaluating CAIX-targeted therapies in triple-negative breast cancer. Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

May 15, 2025FEBS Open BioOpen Access

Development of 4T1 breast cancer mouse model system for preclinical carbonic anhydrase IX studies

View Full Paper

Ask AI

Bookmark

Authors

ZKZane KalniņaLatvian Biomedical Research and Study Centre ILI. LiekninaLatvian Biomedical Research and Study Centre SKSvetlana KotelovičaLatvian Biomedical Research and Study Centre

Discussion

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kalniņa et al. (2025) studied this question.

synapsesocial.com/papers/6a22f10d940447ac22b7a9d7 https://doi.org/10.1002/2211-5463.70052

View Full Paper

Ask AI

Bookmark

May 15, 2025FEBS Open BioOpen Access

Development of 4T1 breast cancer mouse model system for preclinical carbonic anhydrase IX studies

View Full Paper

Ask AI

Bookmark

Authors

ZKZane KalniņaLatvian Biomedical Research and Study Centre ILI. LiekninaLatvian Biomedical Research and Study Centre SKSvetlana KotelovičaLatvian Biomedical Research and Study Centre

Discussion

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kalniņa et al. (2025) studied this question.

synapsesocial.com/papers/6a22f10d940447ac22b7a9d7 https://doi.org/10.1002/2211-5463.70052

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark